These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
540 related articles for article (PubMed ID: 7179995)
1. [Therapy of chronic cardiac insufficiency with cardiac glycosides]. Bonelli J Wien Med Wochenschr; 1982 Oct; 132(19):442-9. PubMed ID: 7179995 [No Abstract] [Full Text] [Related]
2. [The use of proscillaridin A in the therapy of cardiac insufficiency in the aged]. Castrucci D; Morini PL Minerva Med; 1967 Nov; 58(91):3917-21. PubMed ID: 6081708 [No Abstract] [Full Text] [Related]
3. [Modern cardiac glycoside therapy]. Bonelli J Wien Med Wochenschr; 1978; 128(22):689-96. PubMed ID: 735108 [No Abstract] [Full Text] [Related]
4. [Problems of glycoside therapy in kidney insufficiency and uremia]. Rupp M; Brass H; Glöckler D Med Welt; 1981 Jan; 32(4):115-22. PubMed ID: 7207142 [No Abstract] [Full Text] [Related]
5. [Gitoformate and digitoxin as alternatives to kidney-dependent glycosides in the therapy of cardiac insufficiency]. Rietbrock N; Woodcock BG; Hrazdil U Arzneimittelforschung; 1984; 34(8):915-7. PubMed ID: 6541927 [TBL] [Abstract][Full Text] [Related]
6. Treatment of chronic right-heart lesions. Proscillaridin for cor pulmonale and the senile heart. Neumann H Geriatrics; 1966 Jun; 21(6):180-5. PubMed ID: 5949184 [No Abstract] [Full Text] [Related]
7. [Possibilities and problems or long-term therapy using cardiac glycosides]. Gillmann H Z Gesamte Inn Med; 1973 Feb; 28(3):41-5 passim. PubMed ID: 4633782 [No Abstract] [Full Text] [Related]
8. [On the preoperative and postoperative cardiac glycoside therapy]. Endte K; Köle W; Müller V; Werner H Wien Med Wochenschr; 1968 Mar; 118(13):276-80. PubMed ID: 5672069 [No Abstract] [Full Text] [Related]
9. [The effect of cardiac glycosides on the diastole of the heart]. Storz H Dtsch Med Wochenschr; 1970 Jan; 95(5):224-7. PubMed ID: 5410907 [No Abstract] [Full Text] [Related]
10. [Experience with proscillaridin A in cardiac insufficiency]. Feiks FK Wien Med Wochenschr; 1966 Mar; 116(11):237-8. PubMed ID: 5985916 [No Abstract] [Full Text] [Related]
11. [Selection of cardiac glycosides for acute usage]. Beermann B; Lundman T Lakartidningen; 1974 Mar; 71(10):919. PubMed ID: 4826126 [No Abstract] [Full Text] [Related]
16. [Clinical studies with a new cardiac glycoside proscillaridine A (Sandoscill)]. Hansel J Med Klin; 1968 Jun; 63(23):919-22. PubMed ID: 4875202 [No Abstract] [Full Text] [Related]
17. [Directed glycoside therapy of manifest heart insufficiency]. Storz H Med Klin; 1971 Apr; 66(16):587-92. PubMed ID: 5552925 [No Abstract] [Full Text] [Related]
18. The role of the sugar component in cardiac glycosides on their action in patients with auricular fibrillation and congestive failure. Gold H; Kwit NT; Shane SJ; Dayrit C J Clin Pharmacol J New Drugs; 1969; 9(3):148-54. PubMed ID: 5255179 [No Abstract] [Full Text] [Related]
19. [Studies on the relationships between the glycoside dosage effect and pulse frequency behavior]. Döring D; Wenzel V Z Gesamte Inn Med; 1966 Jun; 21(12):Suppl:137-8. PubMed ID: 5987624 [No Abstract] [Full Text] [Related]
20. [Indications and contraindications for therapy with cardiac glycosides]. Haasis R Fortschr Med; 1982 Aug; 100(31-32):1436-9. PubMed ID: 7129303 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]